Immune profiling of murine cardiac leukocytes identifies triggering receptor expressed on myeloid cells 2 as a novel mediator of hypertensive heart failure
Charles D Smart(Vanderbilt University), Meena S. Madhur(Indiana University School of Medicine), Debra Dixon(Vanderbilt University Medical Center), Vineet Agrawal(Vanderbilt University), Matthew A. Cottam(Vanderbilt University), Jean W. Wassenaar(Vanderbilt University Medical Center), Anna R. Hemnes(Vanderbilt University Medical Center), Daniel J. Fehrenbach(Indiana University – Purdue University Indianapolis), Amanda C. Doran(Vanderbilt University), Deepak K. Gupta, Alyssa H. Hasty(Vanderbilt University), Niki Fortune(VA Tennessee Valley Healthcare System)
Cited by 43
Related Papers
Heart Disease and Stroke Statistics—2021 Update
|Circulation|2021|5.7k
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533
Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
|Proceedings of the National Academy of Sciences|1997|289
Immune activation caused by vascular oxidation promotes fibrosis and hypertension
|Journal of Clinical Investigation|2015|231